Market Closed -
Nyse
04:00:01 2024-04-26 pm EDT
|
5-day change
|
1st Jan Change
|
57.12
USD
|
+1.55%
|
|
+0.30%
|
-23.72%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
2,911
|
3,210
|
5,783
|
4,456
|
2,830
|
2,164
|
-
|
-
|
Enterprise Value (EV)
1 |
3,445
|
4,043
|
6,445
|
5,235
|
4,033
|
3,178
|
3,016
|
2,957
|
P/E ratio
|
26
x
|
46.1
x
|
18
x
|
10.4
x
|
14
x
|
33.5
x
|
22.1
x
|
17.5
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
1.31
x
|
1.34
x
|
1.45
x
|
0.85
x
|
0.75
x
|
0.68
x
|
0.66
x
|
0.64
x
|
EV / Revenue
|
1.55
x
|
1.69
x
|
1.62
x
|
1
x
|
1.06
x
|
1
x
|
0.92
x
|
0.88
x
|
EV / EBITDA
|
12.4
x
|
12.6
x
|
10.1
x
|
6.18
x
|
6.96
x
|
8.81
x
|
7.63
x
|
7.69
x
|
EV / FCF
|
18.2
x
|
18.5
x
|
25.6
x
|
9.06
x
|
15
x
|
16.4
x
|
11.2
x
|
8.41
x
|
FCF Yield
|
5.51%
|
5.42%
|
3.91%
|
11%
|
6.66%
|
6.09%
|
8.95%
|
11.9%
|
Price to Book
|
3.95
x
|
3.92
x
|
5.06
x
|
4.13
x
|
3.41
x
|
2.51
x
|
2.4
x
|
2.27
x
|
Nbr of stocks (in thousands)
|
46,711
|
47,031
|
47,275
|
43,336
|
37,789
|
37,889
|
-
|
-
|
Reference price
2 |
62.31
|
68.25
|
122.3
|
102.8
|
74.88
|
57.12
|
57.12
|
57.12
|
Announcement Date
|
2/13/20
|
2/18/21
|
2/17/22
|
2/16/23
|
2/15/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
2,222
|
2,394
|
3,984
|
5,243
|
3,789
|
3,182
|
3,293
|
3,364
|
EBITDA
1 |
277.4
|
320.7
|
635.4
|
846.7
|
579.1
|
360.8
|
395.3
|
384.6
|
EBIT
1 |
176.9
|
149.3
|
478
|
647.1
|
338.4
|
159.4
|
205
|
269.8
|
Operating Margin
|
7.96%
|
6.24%
|
12%
|
12.34%
|
8.93%
|
5.01%
|
6.23%
|
8.02%
|
Earnings before Tax (EBT)
1 |
148.5
|
91.52
|
443.9
|
606.7
|
284.3
|
102.1
|
155.7
|
271.4
|
Net income
1 |
114
|
70.66
|
327.4
|
444
|
210.7
|
72.32
|
111
|
206.3
|
Net margin
|
5.13%
|
2.95%
|
8.22%
|
8.47%
|
5.56%
|
2.27%
|
3.37%
|
6.13%
|
EPS
2 |
2.400
|
1.480
|
6.810
|
9.900
|
5.360
|
1.706
|
2.588
|
3.263
|
Free Cash Flow
1 |
189.6
|
219.1
|
251.8
|
577.9
|
268.5
|
193.7
|
269.9
|
351.5
|
FCF margin
|
8.53%
|
9.15%
|
6.32%
|
11.02%
|
7.09%
|
6.09%
|
8.2%
|
10.45%
|
FCF Conversion (EBITDA)
|
68.37%
|
68.33%
|
39.62%
|
68.25%
|
46.36%
|
53.68%
|
68.29%
|
91.39%
|
FCF Conversion (Net income)
|
166.37%
|
310.09%
|
76.91%
|
130.14%
|
127.43%
|
267.8%
|
243.21%
|
170.4%
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/13/20
|
2/18/21
|
2/17/22
|
2/16/23
|
2/15/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
877.8
|
1,363
|
1,553
|
1,427
|
1,139
|
1,126
|
1,126
|
991.3
|
853.5
|
818.3
|
816.5
|
780.3
|
774.9
|
794.9
|
815.2
|
EBITDA
1 |
138.4
|
222.6
|
257.6
|
232.7
|
181.8
|
174.6
|
179.6
|
161.8
|
133.7
|
104
|
93.6
|
87.7
|
88.17
|
91.21
|
95.25
|
EBIT
1 |
105.8
|
168.6
|
207.9
|
183.5
|
136.4
|
119.3
|
125.7
|
91.66
|
86.93
|
34.17
|
40.41
|
37.96
|
39.06
|
41.2
|
43.8
|
Operating Margin
|
12.06%
|
12.37%
|
13.39%
|
12.87%
|
11.98%
|
10.6%
|
11.16%
|
9.25%
|
10.19%
|
4.18%
|
4.95%
|
4.86%
|
5.04%
|
5.18%
|
5.37%
|
Earnings before Tax (EBT)
1 |
100.6
|
158.8
|
198.3
|
173.5
|
127.4
|
107.5
|
115.4
|
79.49
|
75.38
|
14
|
21.82
|
22.14
|
24.96
|
29.19
|
29.16
|
Net income
1 |
74.02
|
116.2
|
146
|
123.8
|
92.44
|
81.8
|
84.11
|
60.91
|
53.17
|
12.49
|
15.03
|
16.58
|
18.66
|
21.61
|
20.58
|
Net margin
|
8.43%
|
8.53%
|
9.4%
|
8.68%
|
8.12%
|
7.27%
|
7.47%
|
6.14%
|
6.23%
|
1.53%
|
1.84%
|
2.12%
|
2.41%
|
2.72%
|
2.52%
|
EPS
2 |
1.540
|
2.420
|
3.090
|
2.770
|
2.100
|
1.880
|
2.020
|
1.550
|
1.390
|
0.3300
|
0.3931
|
0.3836
|
0.4148
|
0.4860
|
0.4101
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
11/4/21
|
2/17/22
|
5/5/22
|
8/4/22
|
11/3/22
|
2/16/23
|
5/4/23
|
8/3/23
|
11/2/23
|
2/15/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
534
|
833
|
661
|
779
|
1,203
|
1,014
|
852
|
793
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.926
x
|
2.599
x
|
1.041
x
|
0.92
x
|
2.077
x
|
2.81
x
|
2.156
x
|
2.062
x
|
Free Cash Flow
1 |
190
|
219
|
252
|
578
|
268
|
194
|
270
|
351
|
ROE (net income / shareholders' equity)
|
16.6%
|
9.08%
|
33%
|
40.3%
|
22.5%
|
14.6%
|
18%
|
18.4%
|
ROA (Net income/ Total Assets)
|
6.66%
|
3.3%
|
11.9%
|
14.8%
|
7.25%
|
2.6%
|
5.9%
|
6.6%
|
Assets
1 |
1,712
|
2,143
|
2,743
|
3,010
|
2,906
|
2,782
|
1,881
|
3,125
|
Book Value Per Share
2 |
15.80
|
17.40
|
24.20
|
24.90
|
22.00
|
22.70
|
23.80
|
25.10
|
Cash Flow per Share
2 |
4.720
|
5.390
|
6.360
|
14.60
|
9.460
|
6.000
|
7.180
|
9.820
|
Capex
1 |
35.2
|
37.7
|
53.6
|
75.8
|
104
|
68.2
|
73.7
|
69.5
|
Capex / Sales
|
1.58%
|
1.58%
|
1.34%
|
1.45%
|
2.74%
|
2.14%
|
2.24%
|
2.07%
|
Announcement Date
|
2/13/20
|
2/18/21
|
2/17/22
|
2/16/23
|
2/15/24
|
-
|
-
|
-
|
Last Close Price
57.12
USD Average target price
75.12
USD Spread / Average Target +31.52% Consensus |
1st Jan change
|
Capi.
|
---|
| -23.72% | 2.16B | | -14.92% | 84.68B | | +13.30% | 81.12B | | +10.92% | 29.4B | | -12.71% | 16.73B | | -3.06% | 16.36B | | -2.63% | 14.92B | | -3.97% | 11.66B | | -1.42% | 11.72B | | -31.75% | 11.77B |
Other Healthcare Facilities & Services
|